Shanghai JMT-Bio
As of the edition of 20 October 2026, Shanghai JMT-Bio runs 14 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Active | 13 |
| Status not established | 1 |
| Total | 14 |
Where its trials are
- Cancer: 15 trials led
- Lungs and airways: 6 trials led
- Digestive system: 4 trials led